a lot of interest in my thread describing the impact of RSV this year on infants and children in the UK
and questions about whether children are more at risk from RSV or COVID-19 (new🧵) 1/n
RSV (respiratory syncytial virus) is an RNA virus that causes upper and lower respiratory tract infections in children
our recently published review in Vaccine pubmed.ncbi.nlm.nih.gov/33895016/ gives an in-depth introduction to the epidemiology and virology 2/n
In the average year many thousands of children across the UK develop RSV infection: in 2016 there were 36,028 admissions for children <5 in England thorax.bmj.com/content/thorax…@PHardelid with around ~700 intensive care admissions 3/n
In the UK we are lucky to have a highly developed health system which means that if infants & children are very sick, they receive all the support they need whilst they recover from infection 4/n
For this reason deaths from pneumonia are thankfully very rare- an estimated 27 in England in 2018 unicef.org.uk/press-releases… 5/n
(this is not the case in developing countries- an estimated 118,000 infants and children die from this disease globally thelancet.com/journals/lance…@Dr_Ting_Shi@drharish_nair
deaths that could mainly be prevented if these countries had a health system equivalent to ours) 6/n
And what about COVID-19? A recent series of studies (nicely summarised here nature.com/articles/d4158… )
showed an estimated 6,338 admissions for COVID-19 amongst children in the year March 2020-February 2021 7/n
1/5 the number for RSV - with 259 intensive care admissions - and again a very low death rate of 22 deaths, equating to 2 per million children nationally 8/n
So which is more worrying ? 9/n
on balance I think the prospect of a larger than usual RSV season is more concerning than ongoing COVID-19 infections for children < 12
Clearly we'd be better off without either disease! and measures implemented to limit the spread of one will work effectively for the other
as we showed in a paper published @ADC_BMJ adc.bmj.com/content/106/9/… 11/n
As at many points throughout the pandemic, we need to balance carefully the benefits- and potential risks-of unmitigated social interactions in the context of highly transmissible viruses 12/n
Lack of social interaction causes considerable harm for children too bmj.com/content/372/bm… 13/n
However this is also a tremendous opportunity to learn lessons from both diseases, so we can take steps to reduce the burden from RSV AND COVID-19 in the future
END
• • •
Missing some Tweet in this thread? You can try to
force a refresh
a few months ago, a group of us, reading reports of unusual patterns of RSV circulation in Australia (a "winter in summer" ncbi.nlm.nih.gov/pmc/articles/P…)
wondered whether the same might happen this year in the United Kingdom and Ireland 🧵1/n
the premise was simple: could we use a simple online questionnaire, collecting only non-patient identifiable information,
to better understand the geographical dynamics and clinical manifestations of RSV circulation in 2021/22?
It turns out we can 2/n
thanks to BronchSTART, a study powered by hundreds of clinicians in Emergency Departments, working as part of the PERUKI Network, we can now watch this year's RSV epidemic play out in real time 3/n
just finished nights on call, and found that a toxic triad of RSV, rhinovirus and SARS-CoV-2 is starting to stretch the Scottish hospital I work in to its limits
it's only August
what went wrong? 🧵1/n
Problem 1. We failed to contain SARS-CoV-2. 2/n
This is a Problem for 3 reasons.
Firstly, there are the (very) small number of children with serious SARS-CoV-2 infection. 3/n
in a typical year in England, there are ~36,000 admissions for bronchiolitis (mainly caused by Respiratory Syncytial Virus, RSV) in infants under the age of 1 thorax.bmj.com/content/75/3/2… 3/n
firstly: why should we vaccinate?
-to protect children, who can (rarely) develop severe disease, require hospitalisation, and (very rarely) die
-to protect vulnerable individuals who have contact with children
-to achieve herd immunity: 21% of UK population aged under 18 2/n
secondly, what do we need to vaccinate children?
-a vaccine that robustly protects against severe disease AND prevents transmission
-robust safety data, including paediatric-focused studies & post-licensure monitoring for potential rare outcomes like vaccine-associated MIS-C 3/n
to allow sporting events to take place this summer?
Israel Start-Up Nation, a cycling team, already in "close talks with the Israeli Ministry of Health to assess whether, if there are vaccines available after the main programme takes place, the team can be allocated some.” 2/4
and if athletes merit preferential treatment, should other cultural figures (actors, musicians) get preferential treatment too?
I would argue not, but interested to see what @Twitter thinks 3/4